Does the product offer OEM or customized production?

Yes, the company provides customized production of generics and offers GMP OEM services.

What is the lead time for orders?

Peak season lead time is one month, while off-season lead time is within 15 workdays.

What payment terms are accepted?

Accepted terms include T/T, Western Union, Small-amount payment, and Money Gram.

Alzheimer's Disease High Quality GMP OEM Memantine Hydrochloride Tablets 5mg

Name: Alzheimer's Disease High Quality GMP OEM Memantine Hydrochloride Tablets 5mg
Brand: Guangzhou Sinolead Biotech Co., Ltd.
SKU: 1937463131

Guangdong, ChinaGuangzhou Sinolead Biotech Co., Ltd.

US$0.10

30,000 Boxes

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Dossier

Ctd

Transport Package

Free

Model NO.

tablets

Specification

5mg

Trademark

Sinolead

Origin

China

Key features

GMP Certified Quality: Manufactured under strict GMP standards ensuring high quality and safety.

OEM Customization Support: Offers OEM services for customized production of generic pharmaceuticals.

Effective Alzheimer's Treatment: Indicated for treating moderate-to-severe Alzheimer's dementia.

Flexible Packaging Options: Available in 10 tabs/blister, 2 blisters/box packaging configuration.

Global Market Reach: Exports to North America, Europe, Asia, Africa, and Oceania markets.

Fast Lead Time: Off-season lead time within 15 workdays; peak season one month.

Multiple Payment Methods: Supports T/T, Western Union, Money Gram, and small-amount payments.

Established Export Experience: Export experience since 2005 with reliable supply chain capabilities.

Company profile

Importers and Exporters

Guangzhou Sinolead Biotech Co., Ltd.

Guangdong, China

Business Type: Manufacturer/Factory, Trading Company, Group CorporationExport Year: 2005-06-16Nearest Port: Guangzhou, Shenzhen, Hong KongAverage Response Time: ≤15hTerms of Payment: T/T, Western Union, Small-amount payment, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, EXW

AI-Powered supplier vetting

SummaryThe supplier is a pharmaceutical and healthcare product manufacturer with products including glutathione, ceftriaxone sodium, amoxicillin/clavulanate, and customized generics. It reports multiple management, quality, environmental, occupational safety, and pharmaceutical certifications, along with 50 R&D engineers and 50 quality-control staff. Production information confirms several pharmaceutical dosage forms, but does not provide a directly comparable capacity figure. The supplier supports sample-based, flexible, and minor customization, but explicitly lacks ODM services, SDK availability, and recent new-product development. Service procedures exist for supplier approval, assessment, and corrective actions, although records are incomplete; complaint handling has both a clear procedure and follow-up records. It has no overseas warehouse, showroom, agents, branches, or offline trade-show experience. The company states that it has registered hundreds of pharmaceutical and healthcare products worldwide and...

Supplier typeThe supplier is positioned as a pharmaceutical and healthcare manufacturer, with listed products such as injectable ceftriaxone, glutathione, oral suspension, and customized generics. Its stated activities also include supporting product registration and regulatory dossier compliance, indicating a manufacturing-oriented pharmaceutical supplier rather than a general trading-only provider.

CertificationsThe supplier lists a broad range of certifications and management-system standards, including GMP, ISO 9001, ISO 14001, ISO 14000, HACCP, BSCI, OHSAS/OHSMS 18001, and others. The slice identifies certification holdings but does not provide certificate numbers, validity periods, or scope details.

After-Sales capabilityThe supplier has a clear complaint-handling procedure with followed records, and it accepts multiple service quotation and payment terms with stated lead times within 15 working days in both peak and off-season. However, it has no overseas warehouse, showroom, overseas agents or branches, and has no overseas-service country coverage, limiting evidence of localized after-sales support.

R&D capabilityThe supplier reports 50 R&D engineers, but explicitly states that it had no new products during the past year and no available SDK. It also does not provide ODM services, so the evidence shows established R&D staffing but limited demonstrated recent innovation.

Production capacityThe supplier lists production of multiple pharmaceutical products and dosage forms, including tablets, injections, and oral suspension, and identifies pharmaceuticals and customized generics among its product keywords. It also reports 50 quality-control staff, but the provided production-output statement is not a directly usable capacity metric for comparison.

Customization capabilityThe supplier explicitly offers customization from samples, flexible customization, and minor customization. This supports tailored production, although the supplier separately states that it does not provide ODM services.

Product Q&A

Q:What is the primary indication for this medication?

It is indicated for the treatment of moderate-to-severe Alzheimer's dementia.

Q:How should the dosage be initiated and increased?

Start with 5 mg daily for week 1, 10 mg for week 2, 15 mg for week 3, and 20 mg daily from week 4 onwards.

Q:Is dose adjustment needed for patients with renal impairment?

No adjustment is needed for mild impairment. For moderate impairment, reduce to 10 mg daily. It is not recommended for severe impairment.

Q:Can this medication be taken with food?

Yes, Memantine tablets can be taken on an empty stomach or with food.

Q:What are the precautions for patients with liver or heart conditions?

There is limited data for liver impairment. Patients with myocardial infarction, heart failure, or uncontrolled hypertension require close monitoring.